# Desferal

NDC: 0078-0467
Generic name: deferoxamine mesylate
Labeler / Manufacturer: Novartis Pharmaceuticals Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Marketing started: 19680402

FDA application: NDA016267

## Active ingredients

- DEFEROXAMINE MESYLATE: 500 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0078-0467"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0078-0467
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a7174843-5965-49fc-b842-f7eff7b48bbc